Skip to main content
OpenTrials
Completed

NCT Number: NCT07125599

The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia

pregnant women diagnosed with severe preeclampsia were subjected to • Full history taking including a detailed history of the hypertension state during the current pregnancy (onset, course, current medication, and whether the blood pressure is controlled or not).gravidity , parity mode of delivery any medical disorders, the presence of headache ,blurring of vision and epigastric pain.

* Complete physical examination: general (including BMI & blood pressure measurement) and obstetric examinations. * Routine obstetric ultrasound and Doppler indices Including umbilical artery Doppler (RI). * Laboratory investigations :

1. Complete blood count (CBC). 2 albuminuria will be detected by dipstick kits . 3. Liver enzymes & kidney function. 4.PT,PC,INR. * Pelvic-Abdominal ultrasound to assess the presence of ascites Ultrasound examination will be performed by a consultant obstetrician to detect free fluid in the peritoneal cavity, especially at hepato-renal pouch, sub-splenic area, or para-colic gutters.

The presence of ascites will be further confirmed at the time of delivery.

3-All labours will be attended by an expert neonatologist and the following will be recorded:

* APGAR score at (1 min). * The further need for neonatal intensive care unit (NICU) admission. * Perinatal death

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Observational

Primary location

Cairo university

Cairo, Cairo Governorate, 12111, Egypt

About this study

pregnant women diagnosed with severe preeclampsia were subjected to • Full history taking including a detailed history of the hypertension state during the current pregnancy (onset, course, current medication, and whether the blood pressure is controlled or not).gravidity , parity mode of delivery any medical disorders, the presence of headache ,blurring of vision and epigastric pain.

  • Complete physical examination: general (including BMI & blood pressure measurement) and obstetric examinations.
  • Routine obstetric ultrasound and Doppler indices Including umbilical artery Doppler (RI).
  • Laboratory investigations :
  • Complete blood count (CBC). 2 albuminuria will be detected by dipstick kits . 3. Liver enzymes & kidney function. 4.PT,PC,INR.
  • Pelvic-Abdominal ultrasound to assess the presence of ascites Ultrasound examination will be performed by a consultant obstetrician to detect free fluid in the peritoneal cavity, especially at hepato-renal pouch, sub-splenic area, or para-colic gutters.

The presence of ascites will be further confirmed at the time of delivery.

3-All labours will be attended by an expert neonatologist and the following will be recorded:

  • APGAR score at (1 min).
  • The further need for neonatal intensive care unit (NICU) admission.
  • Perinatal death

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Maternal age from 18 to 40 years.
  • Gestational age (28_38) weeks, confirmed by the first day of the last menstrual period or first trimesteric ultrasound
  • All suffering of severe preeclampsia

Exclusion criteria

  • known liver disease
  • Maternal medical disorders rather than hypertension.
  • Rupture of membrane.
  • Renal disorder.
  • History of illicit drug use.
  • Fetal congenital anomalies.
  • The maternal administration of respiratory depressants within 2 hours from the delivery of the fetus (e. g., opioid analgesic )
  • Associated inflammatory disease or sepsis.

Treatment and study plan

Primary outcomes

  1. Number of participants developed eclampsia

    Time frame: 3 days after delivery

    convulsions in women with severe preeclampsia

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

The Association Between Clinical, Laboratory and Ultrasonographic Findings With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia

Important dates

Study start
2020
Primary completion
2025
Study completion
2025
First posted
Aug 15, 2025
Registry last updated
Aug 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.